Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Role of cellular prion protein in interneuronal amyloid transmission

dc.contributor.authorRío Fernández, José Antonio del
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)
dc.contributor.authorGavín Marín, Rosalina
dc.date.accessioned2019-10-08T17:04:24Z
dc.date.available2019-12-01T06:10:16Z
dc.date.issued2018-06-01
dc.date.updated2019-10-08T17:04:24Z
dc.description.abstractSeveral studies have indicated that certain misfolded amyloids composed of tau, β-amyloid or α-synuclein can be transferred from cell to cell, suggesting the contribution of mechanisms reminiscent of those by which infective prions spread through the brain. This process of a 'prion-like' spreading between cells is also relevant as a novel putative therapeutic target that could block the spreading of proteinaceous aggregates throughout the brain which may underlie the progressive nature of neurodegenerative diseases. The relevance of β-amyloid oligomers and cellular prion protein (PrPC) binding has been a focus of interest in Alzheimer's disease (AD). At the molecular level, β-amyloid/PrPC interaction takes place in two differently charged clusters of PrPC. In addition to β-amyloid, participation of PrPC in α-synuclein binding and brain spreading also appears to be relevant in α-synucleopathies. This review summarizes current knowledge about PrPC as a putative receptor for amyloid proteins and the physiological consequences of these interactions.
dc.format.extent16 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec679823
dc.identifier.issn0301-0082
dc.identifier.pmid29530723
dc.identifier.urihttps://hdl.handle.net/2445/141852
dc.language.isoeng
dc.publisherElsevier Ltd
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.pneurobio.2018.03.001
dc.relation.ispartofProgress in Neurobiology, 2018, vol. 165-167, p. 87-102
dc.relation.urihttps://doi.org/10.1016/j.pneurobio.2018.03.001
dc.rightscc-by-nc-nd (c) Elsevier Ltd, 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationAmiloïdosi
dc.subject.classificationPèptids
dc.subject.classificationMetabolisme
dc.subject.classificationAlfa-sinucleïna
dc.subject.classificationProteïnes
dc.subject.otherAmyloidosis
dc.subject.otherPeptides
dc.subject.otherMetabolism
dc.subject.otherAlpha-synuclein
dc.subject.otherProteins
dc.titleRole of cellular prion protein in interneuronal amyloid transmission
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
679823.pdf
Mida:
1.53 MB
Format:
Adobe Portable Document Format